论文信息 - Safety and efficacy of low‐dose MgSO4 in the treatment of eclampsia - 字舞流文

Safety and efficacy of low‐dose MgSO4 in the treatment of eclampsia

S. Saha | J. Kalra | R. Prasad | Shilva

[1] B. Maisch,et al. Clinical and immunologic characteristics in peripartum cardiomyopathy. , 2007, International journal of cardiology.

[2] H. Schultheiss,et al. Viral Persistence in the Myocardium Is Associated With Progressive Cardiac Dysfunction , 2005, Circulation.

[3] Diethelm Wallwiener,et al. High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. , 2005, American journal of obstetrics and gynecology.

[4] A. Begum,et al. A low dose (‘Dhaka’) magnesium sulphate regime for eclampsia , 2001, Acta obstetricia et gynecologica Scandinavica.

[5] A. Begum,et al. A low dose ('Dhaka') magnesium sulphate regime for eclampsia: Clinical findings and serum magnesium levels , 2001 .

[6] A. Patil,et al. Low dose magnesium sulphate therapy for eclampsia and imminent eclampsia: Regime tailored for Indian women , 2000 .

[7] R. Collins,et al. WHICH ANTICONVULSANT FOR WOMEN WITH ECLAMPSIA - EVIDENCE FROM THE COLLABORATIVE ECLAMPSIA TRIAL , 1995 .

[8] The Surfaxin-Lavage for Mas Trial Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial , 1995, The Lancet.

[9] G. Dhall,et al. A Safer and More Effective Treatment Regimen for Eclampsia , 1994, The Australian & New Zealand journal of obstetrics & gynaecology.